BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15370144)

  • 1. ANCA-positive vasculitis of the breast.
    Zardawi IM; Barker BJ; Clark DA; Davies DJ
    Pathology; 2004 Aug; 36(4):370-3. PubMed ID: 15370144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
    Ye H; Gao Y; Guo XH; Zhao MH
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antineutrophil cytoplasmic antibodies during treatment with benzylthiouracil.
    Sghiri R; Ouertani M; Ben Hsine H; Slim I; Chaieb L; Ghedira I
    Pathol Biol (Paris); 2009 Jul; 57(5):410-4. PubMed ID: 19201108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antineutrophil cytoplasmic antibodies and associated diseases].
    Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
    Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis.
    Yu F; Chen M; Gao Y; Wang SX; Zou WZ; Zhao MH; Wang HY
    Am J Kidney Dis; 2007 May; 49(5):607-14. PubMed ID: 17472842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasculitis in elderly patients associated to ANCA].
    García de Vinuesa S; Fernández L; Goicoechea MA; Luño J
    Nefrologia; 2003; 23(4):359-60. PubMed ID: 14558337
    [No Abstract]   [Full Text] [Related]  

  • 7. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
    Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
    J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propylthiouracil induced anti-neutrophil cytoplasmic antibody-associated vasculitis with bone marrow plasmacytosis and granulocytopenia.
    Ozkok A; Salman S; Agan M; Yavuz AS; Yarman S; Boztepe H; Alagol F; Tanakol R
    Chin Med J (Engl); 2009 May; 122(9):1112-4. PubMed ID: 19493451
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with diffuse tubulointerstitial nephritis.
    Son D; Kanda H; Yamaguchi A; Kawabata K; Kawakami T; Kubo K; Higashihara M; Shimizu J; Uozaki H; Kuramochi S; Misaki Y; Takeuchi F; Yamamoto K
    J Nephrol; 2009; 22(3):417-20. PubMed ID: 19557721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibody vasculitis associated with mycobacterium avium intracellulare infection.
    Chaiamnuay S; Heck LW
    J Rheumatol; 2005 Aug; 32(8):1610-2. PubMed ID: 16078343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study.
    Slot MC; Links TP; Stegeman CA; Tervaert JW
    Arthritis Rheum; 2005 Feb; 53(1):108-13. PubMed ID: 15696557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of ANCA-associated vasculitis in post-transplant kidney: relapse and de novo.
    Tabata H; Honda K; Moriyama T; Itabashi M; Taneda S; Takei T; Tanabe K; Teraoka S; Yamaguchi Y; Oda H; Nitta K
    Clin Transplant; 2009 Aug; 23 Suppl 20():49-53. PubMed ID: 19594597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement.
    Kümpers P; Hellpap J; David S; Horn R; Leitolf H; Haller H; Haubitz M
    Nephrol Dial Transplant; 2009 Jun; 24(6):1845-50. PubMed ID: 19164323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibodies (ANCA).
    Radice A; Sinico RA
    Autoimmunity; 2005 Feb; 38(1):93-103. PubMed ID: 15804710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
    Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
    Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.
    Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M
    Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
    Lin W; Chen M; Zhao MH
    Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.